3D Printed Drugs Market Share

Regionally, the global 3D printed drugs market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2037 owing to the growing incidence of chronic diseases and increasing health awareness among people. For instance, 44% of the population suffers from at least one chronic illness, which amounts to over 132 million Americans. Over 1.6 million Americans die every year from chronic diseases in the United States. Furthermore, the well-developed domestic healthcare infrastructure, extensive research and development, and increasing technological advancements in the North America region are anticipated to drive the regional market growth over the forecast period.